| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/12/2008 | CN101142225A Macrolides with anti-inflammatory activity |
| 03/12/2008 | CN101142195A Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of C N S disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates |
| 03/12/2008 | CN101142189A 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 03/12/2008 | CN101142188A 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 03/12/2008 | CN101142185A Indoles useful in the treatment of inflammation |
| 03/12/2008 | CN101141973A Herbal preparation for joints |
| 03/12/2008 | CN101139393A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139392A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139345A Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 03/12/2008 | CN101139343A Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
| 03/12/2008 | CN101138628A Chinese medicine for treating common cold in any season |
| 03/12/2008 | CN101138626A Bone-through ache-treating emplastrum |
| 03/12/2008 | CN101138625A Chinese medicine composition for treating omarthritis |
| 03/12/2008 | CN101138618A Chinese medicine for treating tuberculosis fever |
| 03/12/2008 | CN101138617A Multiple-effect paste for activating blood circulation and removing stasis |
| 03/12/2008 | CN101138614A Chinese traditional medicine for treating exogenous fever |
| 03/12/2008 | CN101138607A Sea snake bining sugar-coating tablets and preparation method thereof |
| 03/12/2008 | CN101138605A Chinese medicine for treating summer heat-dampness rheum |
| 03/12/2008 | CN101138594A Quality control method of traditional chinese medicine preparation for treating traumatic injury and rheumatism ostealgia |
| 03/12/2008 | CN101138592A Preparation method for treating internal hemorrhoid and Chinese medicine suppository thereof |
| 03/12/2008 | CN101138590A Use of medicinal fatheadtree leaf in the preparation of antimicrobial anti-inflammation medicament |
| 03/12/2008 | CN101138574A Wine-fried angelica decocting pieces, preparation method thereof and application thereof |
| 03/12/2008 | CN101138571A Hyperosteogeny-against and rheumatism-against inunction agentia |
| 03/12/2008 | CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds |
| 03/12/2008 | CN101138553A Anisodamine freeze drying preparations for injections and preparation method |
| 03/12/2008 | CN101138544A Diclofenac or the salt thereof partial film forming gel composition and uses thereof |
| 03/12/2008 | CN100374466C Antibodies against human IL-12 |
| 03/12/2008 | CN100374454C preparation method of 2-aminocarbonyl-9h-purine derivatives and intermediate thereof |
| 03/12/2008 | CN100374443C Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition |
| 03/12/2008 | CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
| 03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
| 03/12/2008 | CN100374040C Bamboo salt preparation method |
| 03/11/2008 | US7342125 Administering derivatives of Kauranoic acid; cachexia, analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, otitis media, sinusitis, antidiabetic agent |
| 03/11/2008 | US7342115 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 03/11/2008 | US7342106 Human antihuman MCP-1 antibody and antibody fragment thereof |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342021 Phosphodiesterase 4 inhibitors |
| 03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
| 03/11/2008 | US7342017 Vanilloid Receptor 1 and metabotropic glutamate receptor 1 inhibitors; inhibition of capsaicin-induced or PH-induced activation of vanilloid receptors; antidepressant; anxiolytic agent; analgesics; addictive disorders; antiemetic agent |
| 03/11/2008 | US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 03/11/2008 | CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/11/2008 | CA2335104C Arylalkanoylpyridazines |
| 03/11/2008 | CA2293382C Piperazine derivatives and their use as anti-inflammatory agents |
| 03/11/2008 | CA2195425C Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 03/11/2008 | CA2150355C Process of resolving phenylpropionic acids using alpha-methylbenzylamine |
| 03/06/2008 | WO2008027350A2 Acetaminophen pharmaceutical compositions |
| 03/06/2008 | WO2008026776A1 Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008026687A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 03/06/2008 | WO2008026473A1 Method for production of hop preparation, hop preparation, antiinflammatory agent, food/beverage, and oral product |
| 03/06/2008 | WO2008026320A1 ANTI-ANGIOGENIC AGENT, DNA SYNTHESIS INHIBITOR, p44/p42 MAPK PHOSPHORYLATION ACTIVITY INHIBITOR, AND MEDICAL KIT |
| 03/06/2008 | WO2008026018A1 New method for the treatment of inflammatory diseases |
| 03/06/2008 | WO2008025964A2 Antibodies to an epitope of agr2. assays and hybridomas |
| 03/06/2008 | WO2008025822A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/06/2008 | WO2008025821A1 Triazole derivatives as kinase inhibitors |
| 03/06/2008 | WO2008025539A1 Heterocyclic fxr binding compounds |
| 03/06/2008 | WO2008025130A1 Method for ameliorating pain by modification of nmda receptors through inhibition of src |
| 03/06/2008 | WO2008003855A3 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 03/06/2008 | WO2008003484A8 Agent containing chrysin and cholic acid for reducing weight, accelerating lipid catabolism, and/or restricting calories |
| 03/06/2008 | WO2007141284A3 Treatment of gastrointestinal disorders with cgrp antagonists |
| 03/06/2008 | WO2007087154A3 Methods for enhancing therapeutic effects of a neurotoxin |
| 03/06/2008 | WO2007078874A3 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| 03/06/2008 | WO2007036920A3 Therapeutic use of polyanhydroglucronic acid |
| 03/06/2008 | US20080058423 Melanin concentrating hormone antagonists |
| 03/06/2008 | US20080058412 1-(4-((R,S)-5-[1,2]dithiolan-3-ylpentyloxy)-3,5-dimethylphenyl)-3-(4-carboxydimethylmethyloxy-3,5-dimethylphenyl)prop-2-en-1-one; peroxisome proliferator activated receptor agonist; lipid or glucose metabolism: hyperlipidemia, diabetes, obesity; dermatologicalal: psoriasis, atopic dermatitis, acne |
| 03/06/2008 | US20080058401 1-(2-(3,3-dimethylbutyl)-4-(trifluoromethyl)benzyl)-3-(1-methyl-1H-indazol-4-yl)urea; transient receptor potential vanilloid-1 (TRPV1) antagonist; low inhibitory activity against drug metabolism enzyme CYP3A4; antinociceptive, analgesic, antiinflammatory, antischemic agent; neuropatic pain |
| 03/06/2008 | US20080058377 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)-N'-[4-(trifluoromethyl)benzyl] urea; antiinflammatory agent: asthma or COPD, analgesic: neuralgia, neuropathies, algesia, nerve injury, ischemia, neurodegeneration, or stroke; urological diseases: urinary incontinence or overactive bladder |
| 03/06/2008 | US20080058369 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058335 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
| 03/06/2008 | US20080058321 Benzothiazin-3-one compound and intermediate therefor |
| 03/06/2008 | US20080058303 Antiinflammatory agents |
| 03/06/2008 | US20080058293 Quinoline Derivates and Their Use in Therapy |
| 03/06/2008 | US20080058284 Pharmaceutical compositions of semicarbazones and/or thiosemicarbazones and/or their derivatives and products of these compositions and their uses as anticonvulsant, anti-nociceptive and anti-inflammatory agents, and in the angiogenic therapy |
| 03/06/2008 | US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators |
| 03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057128 Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from |
| 03/06/2008 | US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 03/06/2008 | US20080057091 Moisturizing, cosmetic, or anti-wrinkle composition comprising at least two hyaluronic acid fractions or salts thereof, wherein first fraction has molecular weight of 8,000-100,000 Da, and second fraction has molecular weight of 500,000-1,100,000 Da; may also have use in treating osteoarthritis, cancer |
| 03/06/2008 | DE102006041525A1 Use of ginger to slow or reverse the growth of rapidly developing tumors in animals and humans |
| 03/06/2008 | CA2662172A1 Method for ameliorating pain by modification of nmda receptors through inhibition of src |
| 03/06/2008 | CA2662074A1 Triazole derivatives as kinase inhibitors |
| 03/06/2008 | CA2661850A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| 03/05/2008 | EP1895017A2 Use of A33 antigens and JAM-IT |
| 03/05/2008 | EP1894931A1 Triazole derivatives as kinase inhibitors |
| 03/05/2008 | EP1894928A1 Heterocyclic fxr binding compounds |
| 03/05/2008 | EP1894925A1 Imidazole compounds having an antiinflammatory effect |
| 03/05/2008 | EP1894572A1 Therapeutic agent and/or prophylactic agent for neurogenic pain |
| 03/05/2008 | EP1893620A2 Substituted spiro compounds and their use for producing pain-relief drugs |
| 03/05/2008 | EP1893614A1 Inhibitor compounds |
| 03/05/2008 | EP1893589A1 Substituted n-benzo [d] isoxazol-3-yl-amine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments |
| 03/05/2008 | EP1893583A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists |
| 03/05/2008 | EP1893191A1 Medicinal acidic cannabinoids |
| 03/05/2008 | EP1697362B1 Crf receptor antagonists and methods relating thereto |
| 03/05/2008 | EP1411919B1 (-)-olivil as antioxidant |
| 03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
| 03/05/2008 | CN101137622A Substituted gamma lactams as therapeutic agents |
| 03/05/2008 | CN101137397A Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 03/05/2008 | CN101137382A Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |